As of 2026-09-21, the Relative Valuation of Reneo Pharmaceuticals Inc (RPHM) is (23.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of Reneo Pharmaceuticals Inc based on Relative Valuation is -1393.4%.
The range of the Relative Valuation is (22.50) - (22.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.8x - 29.3x | 26.6x |
| Forward P/E multiples | 22.6x - 23.9x | 23.2x |
| Fair Price | (22.50) - (22.59) | (23.54) |
| Upside | -1336.3% - -1341.5% | -1393.4% |
| Date | P/E |